KDR and cancer: GDF6 upregulates the VEGFR/PI3K-Akt pathway, enhancing endothelial cell recruitment and vascularization [20], and collaborates with HIF-1α to regulate hypoxia responses and recruit cancer-associated fibroblasts (CAFs), fostering an immunosuppressive niche [21].